Is Former CStone Chairman the Medicine Ailing Hengrui Needs?
Hengrui Medicine started the New Year by naming CStone’s previous top official Jiang Ningjun as its new vice general manager and chief strategy officer.Key Takeaways:Hengrui Pharma has named the former…
Recent Articles
RELATED ARTICLES
-
Hengrui Pharma accelerates bid for global brand status
600276.SHG -
Earnings blow for CSPC Pharma as the state drives a hard bargain
1093.HK
-
Everest Medicines eyes mRNA tumor vaccines as drug valuations rebound
1952.HK
- Former TV magnate tries his luck at EVs with IPO plans in sight
-
No respite for RemeGen as problems and losses pile up
9995.HK 688331.SHG
-
Everest gets boost from core product Nefecon’s inclusion in China’s national health plan
1952.HK
-
Xuanzhu Biopharm set for spin-off in Hong Kong IPO
0460.HK
